Focused on evaluating the commercial attractiveness of the3DDA solution market. We also validated the investment thesis – that the target would be astrategic extensionfor our client’s medical book assets because it capitalized on the growing adoption of digital and virtual reality technologies
Key questions
As part of our CDD process, we focused on the following questions:
What was the sub-segment size and notional opportunity for 3DDA tools?
Who are the addressable users?
What is the range of content and related tools used by students and medical /nursing schools for foundational and advanced anatomy courses?
To what extent do current solutions address customer needs?
What were the relative strengths and weaknesses of the target and competitors’ capabilities and products across the identified use cases/feature set?
What were the synergies between our client the target business?
Methodology highlights
Conducted targeted interviews with market experts, current and prospective customers of the target company, competitors’ B2B customers, our client’s B2B customers, and competing vendors
Sized the relevant sub-segment using both supply and demand-side methodology
Re-built the business plan for both B2B and B2C customers within a tight timeframe with limited access to target management/customer data
Results
Based on our insights, our client acquired the company successfully two months after we delivered the project.
In part two of this three part series, Stax experts Athan Siah and Harry Stuart dive into customer closeness and how investors can develop insight into participant objectives when assessing B2B event organizers.
Stax experts Athan Siah and Owen Tindle offer insight into the sports management software market, including macro trends and drivers, the role of software & technology, and positive tailwinds. Click to learn more.
By Florent Jarry & Christine O'Connell•02 May, 2024
Stax and Baird hosted a private event discussing AI Disruption in Business Information with guest speakers from OpenAI and Forefront Advisors to discuss examples of GenAI implementations and the evolving regulatory landscape. Read more.
Stax is pleased to welcome Andrew Keller to the London office as a Director. Andrew will oversee the technology market coverage for U.K. and EMEA. Click to learn more.